Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: SOP for Osmolarity Testing of Ophthalmic Solutions – V 2.0

Posted on By

Analytical Method Development: SOP for Osmolarity Testing of Ophthalmic Solutions – V 2.0

Standard Operating Procedure for Osmolarity Testing of Ophthalmic Solutions in Analytical Method Development


Department Analytical Method Development
SOP No. SOP/AMD/250/2025
Supersedes SOP/AMD/250/2022
Page No. Page 1 of 12
Issue Date 21/05/2025
Effective Date 23/05/2025
Review Date 21/05/2026

1. Purpose

To establish a standardized procedure for measuring the osmolarity of ophthalmic solutions using a freezing point depression osmometer, ensuring the tonicity of the product is suitable for

ocular administration.

2. Scope

This SOP applies to Analytical Method Development (AMD) personnel responsible for determining osmolarity of eye drop formulations during formulation development, stability studies, and routine quality control analysis.

3. Responsibilities

  • Analytical Scientist: Conducts the osmolarity test, documents results, and maintains instrument calibration records.
  • QC Analyst: Assists in sample preparation and verification of test standards.
  • QA Executive: Reviews osmolarity test results and approves data sheets.
See also  Analytical Method Development: SOP for System Performance Qualification of FTIR Spectrophotometer - V 2.0

4. Accountability

The Head of Analytical Method Development is accountable for ensuring accuracy, repeatability, and compliance of the osmolarity test method with regulatory and pharmacopeial standards.

5. Procedure

5.1 Principle

Osmolarity is determined by measuring the freezing point depression of a solution using a cryoscopic osmometer. The degree of freezing point depression correlates with the number of solute particles, expressed in milliosmoles per kilogram (mOsm/kg).

5.2 Equipment and Materials

  1. Freezing Point Depression Osmometer (e.g., Advanced Instruments, Model 3320)
  2. Osmolarity calibration standards (100, 290, and 1000 mOsm/kg)
  3. Disposable sample tubes or cups
  4. Micropipettes (50–100 µL range)
  5. Ophthalmic formulation sample

5.3 Instrument Calibration

  1. Calibrate the osmometer daily using 100 and 290 mOsm/kg standards.
  2. Run 3 replicates for each standard and verify that values are within ±2% of nominal value.
  3. Document calibration results in the calibration log (Annexure-2).

5.4 Sample Testing Procedure

  1. Allow sample to reach room temperature (20–25°C).
  2. Mix the sample gently to ensure homogeneity.
  3. Using a micropipette, transfer 50 µL of the ophthalmic sample into the sample tube.
  4. Insert the tube into the osmometer and initiate the test.
  5. Record the result displayed in mOsm/kg.
  6. Repeat for triplicate readings per sample and calculate the average.
See also  Analytical Method Development: HPLC Content Uniformity Method - V 2.0

5.5 Acceptance Criteria

  1. Osmolarity range for ophthalmic solutions: 270–330 mOsm/kg.
  2. Results must be consistent within ±5 mOsm/kg across replicates.

5.6 Method Validation Parameters

  1. Repeatability: % RSD ≤ 2.0% across triplicates.
  2. Linearity: Verify linearity across 100–1000 mOsm/kg.
  3. Accuracy: Spike placebo with known concentrations and assess recovery.

5.7 Documentation

  1. Record osmolarity values, instrument ID, analyst initials, and test conditions.
  2. Attach raw printouts or screenshots from osmometer for each batch tested.

6. Abbreviations

  • mOsm/kg: Milliosmoles per kilogram
  • QA: Quality Assurance
  • AMD: Analytical Method Development
  • RSD: Relative Standard Deviation

7. Documents

  1. Osmolarity Test Log – Annexure-1
  2. Osmometer Calibration Log – Annexure-2
  3. Osmolarity Validation Report – Annexure-3

8. References

  • USP <785>: Osmolality and Osmolarity
  • EP 2.2.35: Osmolality
  • ICH Q6A: Specifications – Test Procedures and Acceptance Criteria

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name Sachin Bhate Riya Kapoor Sunita Reddy
Designation Analytical Chemist QA Reviewer Head – AMD
Department Analytical Method Development QA Analytical Method Development

11. Annexures

Annexure-1: Osmolarity Test Log

Batch No. Sample Name Replicate 1 Replicate 2 Replicate 3 Average (mOsm/kg) Status
OPH-250-01 Lubricant Eye Drops 292 295 294 293.7 Pass

Annexure-2: Osmometer Calibration Log

Date Standard (mOsm/kg) Measured Value Deviation (%) Status
20/05/2025 290 288.6 -0.5 Pass

Annexure-3: Osmolarity Validation Report

The osmolarity testing method using freezing point depression osmometer was validated for ophthalmic formulations. Precision was 1.3% RSD, recovery ranged from 98–102%, and linearity was established across 100–1000 mOsm/kg. Method approved for routine and stability testing.

Revision History:

Revision Date Revision No. Details Reason Approved By
21/05/2025 2.0 Expanded validation criteria and updated references Annual SOP Review Sunita Reddy
01/03/2022 1.0 Initial Release New SOP QA Head
See also  Analytical Method Development: SOP for Development of Subvisible Particulate Matter Test - V 2.0
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Manufacturing: SOP for Controlling Particle Contamination in Aseptic Areas – V 2.0
Next Post: Ensuring Integration of Third-Party SOPs into Internal Quality Systems

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version